肉毒素A在治疗干眼疾病方面是否有效? 一个系统的审查和元分析
Kai-Yang Chen1, Hoi-Chun Chan2, Chi-Ming Chan3,4
1School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Eye (London, England)
|April 9, 2025
概括
毒素A (BTX-A) 显著改善了干眼疾病 (DED) 的结果. 这一元分析表明,BTX-A增强了膜的稳定性和产生,并减少了症状,支持其用于DED治疗.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 干眼病 (DED) 是一种多因素状况,影响膜稳定性,眼睛表面炎症和神经传感功能.
- 毒素A (BTX-A) 对DED的治疗潜力仍然不完全理解.
研究的目的:
- 通过全面的元分析,系统地评估BTX-A在DED管理中的有效性.
- 综合现有关于BTX-A对关键DED临床标志物的影响研究的证据.
主要方法:
- 在主要数据库 (PubMed,Cochrane Library,Scopus,Web of Science,Embase) 进行了系统的文献搜索,截至2024年12月.
- 包括的研究是随机对照试验 (RCT) 和非RCT评估BTX-A对DED的影响,重点关注撕裂破裂时间 (TBUT),希尔默测试得分,撕裂半月膜高度 (TMH) 和眼睛表面疾病指数 (OSDI).
- 用固定和随机效应模型分析数据,以解释统计异质性.
主要成果:
- 分析了14项涉及634名患者的研究.
- BTX-A治疗带来了显著的改善:TBUT增加了1.79s (p<0.00001),施尔默测试得分提高了3.72mm (p<0.00001),OSDI得分降低了-7.51分 (p<0.00001).
- 撕裂阴囊高度 (TMH) 也显示显著增加0.10mm (p<0.00001).
结论:
- 这一元分析提供了强有力的证据,证明BTX-A是一种有效的治疗方法,可以改善DED患者的临床结果.
- BTX-A在催产生,催膜稳定性和症状缓解方面表现出好处,将其定位为DED管理的有前途的治疗选择.
相关概念视频
Open Angle Glaucoma: Treatment
383
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
383
Direct-Acting Cholinergic Agonists: Therapeutic Uses
663
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
663
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
642
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
642
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K


